treamid
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 25, 2016 (NCT04428593)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=C(CCCC(=O)NCCc1ncc[nH]1)NCCc1ncc[nH]1- Mol. weight
- 318.38 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095199 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05516550 | Phase 2/Phase 3 (Phase 3) | Aug 31, 2022 | Pharmenterprises LLC |
| NCT04527354 | Phase 2 | Sep 8, 2020 | Pharmenterprises LLC |
| NCT04428684 | Phase 1 | Oct 29, 2018 | Peptigroupe Inc, Pharmaxi LLC |
| NCT04428593 | Phase 1 | Jan 25, 2016 | Government of Russia, Pharmenterprises LLC |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmenterprises LLC | For profit | 3 | 3 | 3 | 2016 |
| Government of Russia | Government | 1 | 0 | 1 | 2016 |
| Peptigroupe Inc | For profit | 1 | 1 | 1 | 2018 |
| Pharmaxi LLC | For profit | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1